RIPK3 and neoplasm: For instance, RIPK3 activation-triggered de-inhibition of tripartite motif protein 28 (TRIM28) in tumor cells results in increased immunostimulatory cytokine production within the tumor microenvironment and thus contributes to robust cytotoxic antitumor immunity (Park H. H. et al., 2021).